First-in-Man Study of a Cardiac Extracellular Matrix Hydrogel in Early and Late Myocardial Infarction Patients

This study evaluated the safety and feasibility of transendocardial injections of VentriGel, a cardiac extracellular matrix hydrogel, in early and late post–myocardial infarction (MI) patients with left ventricular (LV) dysfunction. VentriGel was delivered in 15 patients with moderate LV dysfunction...

Descripción completa

Detalles Bibliográficos
Autores principales: Traverse, Jay H., Henry, Timothy D., Dib, Nabil, Patel, Amit N., Pepine, Carl, Schaer, Gary L., DeQuach, Jessica A., Kinsey, Adam M., Chamberlin, Paul, Christman, Karen L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
CLINICAL RESEARCH
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6834965/
https://www.ncbi.nlm.nih.gov/pubmed/31709316
http://dx.doi.org/10.1016/j.jacbts.2019.07.012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6834965/
https://www.ncbi.nlm.nih.gov/pubmed/31709316
http://dx.doi.org/10.1016/j.jacbts.2019.07.012

Ejemplares similares